Furthermore, leptin was reported to elicit chemoresistance in pancreatic ductal adenocarcinoma, and the results indicated that gemcitabine resistance develops via miR-342-3p upregulation-dependent inhibition of KLF6 signaling in cancer cells [86]. Here, LEP is linked to cancer.